Experian Jumps to 6th on 2023 IDC FinTech Rankings Top 100
Experian has been ranked 6th on the 2023 IDC FinTech Rankings, jumping from last year’s position at 9th. The FinTech Rankings evaluate the top 100 providers of financial technology based on 2022 calendar year revenues from the financial services and FinTech industries. In addition, Experian was recognized as an IDC Fintech Top 100 Fast Track FinTech recipient, given to companies that have noticeably grown year over year on IDC’s FinTech Rankings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230919170411/en/
“These honors reflect the incredible efforts of the people who work at Experian. It is a group of people who is dedicated to doing the right things for our customers, nurturing a culture of innovation, and relentlessly focused on translating the investments and roadmap decisions we make into direct value for buyers of our applications and platform,” said Alex Lintner, Chief Executive Officer, Experian Software Solutions. “Our teams are passionate about understanding the unique needs of our clients and they always aim to deliver advanced modeling and comprehensive data insights that accelerate the pace of progress in our customers’ business, foster greater financial inclusion and mitigate risk from increasingly sophisticated forms of fraud, all of which drives greater customer satisfaction and adoption of our technology.”
A key innovation that helped enable advanced modeling and decisioning for customers is the award-winning Experian Ascend Technology Platform™ that supports the full development lifecycle of custom features and models for various business outcomes, be it credit risk, marketing or fraud. Ascend Ops™ is an innovative model deployment solution that helps customers move models seamlessly into production in days instead of months. “Our Ascend technology helps our customers accelerate the use of advanced analytics and machine learning capabilities to react to changing market conditions, test and learn, and get changes to production much quicker and cost effectively,” added Lintner.
“In the 2023 IDC FinTech Rankings program, Experian is ranked as the 6th largest global provider of technology solutions to the financial services industry and has also been identified as a FastTrack FinTech based on their movement up the list year over year,” says Marc DeCastro research director at IDC. “Experian has the scale to provide financial institutions with the tools and solutions necessary to remain competitive in a rapidly changing and competitive marketplace.”
In its 20th year, the IDC FinTech Rankings represent the leading global hardware, software and service providers to the financial services industry. To view the complete rankings, visit https://www.idc.com/prodserv/insights/financial/fintech-rankings.
About Experian
Experian is the world’s leading global information services company. During life’s big moments – from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers – we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.
We have 22,000 people operating across 32 countries and every day we’re investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. With corporate headquarters in Dublin, Ireland, we are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.
Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.
Experian and the Experian marks used herein are trademarks or registered trademarks of Experian and its affiliates. Other product and company names mentioned herein are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919170411/en/
Contact information
Michael Troncale
Experian Public Relations
+1 714 830 5462
michael.troncale@experian.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wolters Kluwer Ranks First in Dresner 2025 Wisdom of Crowds® Financial Consolidation, Close Management and Financial Reporting Market Study23.10.2025 16:30:00 EEST | Press release
Wolters Kluwer, a global leader in professional information, software solutions and services, today announced that its CCH® Tagetik Intelligent Platform has achieved the top position in the Dresner Advisory Services 2025 Wisdom of Crowds® Financial Consolidation, Close Management and Financial Reporting (FCCR) Market Study. This marks the second straight year that Wolters Kluwer has earned the study’s number one ranking. Access the Dresner Advisory Services 2025 Wisdom of Crowds® Financial Consolidation, Close Management and Financial Reporting (FCCR) Market Study. This study is part of Dresner Advisory Services’ ongoing research into the enterprise performance management (EPM) space and focuses specifically on performance management capabilities targeted at the finance function, including financial consolidation, close management and financial reporting. The study also identifies user trends, priorities, adoption patterns, and vendor performance, helping organizations make informed de
Andersen Consulting Collaborates with Acronotics to Deepen AI-led Digital Transformation Capabilities23.10.2025 16:30:00 EEST | Press release
Andersen Consulting strengthens its technology and business transformation capabilities through a Collaboration Agreement with Acronotics, a rapidly growing digital consulting firm headquartered in the UK with a presence in the U.S. and India. As a specialist in AI-led business transformation, Acronotics works with Fortune 500 companies to accelerate digital transformation by harnessing the power of AI. The firm has deep expertise across manufacturing, banking and financial services, retail, fast-moving consumer goods, and high-tech industries, with a strong focus on AI/ML, Generative AI, and RPA technology stacks. Acronotics delivers end-to-end services including the design, development, and implementation of Agentic AI and RPA-based process automation solutions. Leveraging its proprietary Automated Digital Worker Management platform, Radium.ai, the firm helps clients manage and monitor their digital workforce effectively. "Collaborating with Andersen Consulting enables us to scale gl
Crexendo and NUSO Partner to Deliver Global Cloud Communications Capabilities23.10.2025 16:15:00 EEST | Press release
NUSO, a leading provider of cloud communications service delivery, today announced it has been chosen by Crexendo®, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication as a service (UCaaS) offerings, including voice, video, contact center, and managed IT services tailored to businesses of all sizes, to be a preferred carrier for the Crexendo cloud communications platform. The expanded partnership allows Crexendo platform licensees to offer cloud communications capabilities over NUSO’s global delivery network, unlocking new revenue opportunities for service providers. With NUSO’s carrier footprint in more than 40 countries, the Crexendo platform now offers global service delivery with industry-leading call quality, uptime, and emergency calling compliance. Platform providers can now offer global service delivery to over 6 million end users worldwide who rely on Crexendo’s Netsapien
SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility23.10.2025 16:03:00 EEST | Press release
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facility to expand and equip a new lab and CGMP-Kilo-scale facility for Solid-Phase Peptide Synthesis (SPPS) and purification. This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing. "The investment in our California facility represents a key milestone in our strategic growth and demonstrates an unwavering dedication to the domestic biopharma sector,” said Joerg Ahlgrimm, CEO of SK pharmteco. “Peptides are a vital and rapidly advancing therapeutic category. This project highlights our ongoing commitment to furthering their development and manufacturing.” “We are expanding our capacity to meet the increasing
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK ® at the North American Cystic Fibrosis Conference23.10.2025 16:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s most recently approved medicine, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), at the North American Cystic Fibrosis Conference (NACFC) held from October 22-25 in Seattle, Washington. Several of the abstracts that will be presented at this year’s conference demonstrate that improvement in CFTR function, as measured by reduction in sweat chloride (SwCl), is associated with improved outcomes in people with cystic fibrosis (CF). ALYFTREK has shown greater reductions in sweat chloride compared to TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Phase 3 trials, suggesting that ALYFTREK has the potential for even greater improvements in quality of life and other health-related outcomes. Data being presented on ALYFTREK and on correlation between lower SwCl and improved clinical
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom